#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	326	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1040	16.8	0	.	p	.	0	K29T	NONSYN	85	87	AAG	282	284	ACG	22;22;22	A;C;G	22;22;22	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	194	Chlamydophila_psittaci_16S	1507	138	90.58	Chlamydophila_psittaci_16S.l6.c4.ctg.1	167	9.7	0	.	n	.	0	A867G	SNP	867	867	A	33	33	G	1	G	1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	194	Chlamydophila_psittaci_16S	1507	138	90.58	Chlamydophila_psittaci_16S.l6.c4.ctg.1	167	9.7	0	.	n	.	0	T879G	SNP	879	879	T	45	45	G	4	G	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	194	Chlamydophila_psittaci_16S	1507	138	90.58	Chlamydophila_psittaci_16S.l6.c4.ctg.1	167	9.7	0	.	n	.	0	G880A	SNP	880	880	G	46	46	A	4	A	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	194	Chlamydophila_psittaci_16S	1507	138	90.58	Chlamydophila_psittaci_16S.l6.c4.ctg.1	167	9.7	0	.	n	.	0	A888G	SNP	888	888	A	54	54	G	7	G	7	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	194	Chlamydophila_psittaci_16S	1507	138	90.58	Chlamydophila_psittaci_16S.l6.c4.ctg.1	167	9.7	0	.	n	.	0	C897G	SNP	897	897	C	63	63	G	8	G	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	194	Chlamydophila_psittaci_16S	1507	138	90.58	Chlamydophila_psittaci_16S.l6.c4.ctg.1	167	9.7	0	.	n	.	0	T898C	SNP	898	898	T	64	64	C	9	C	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	194	Chlamydophila_psittaci_16S	1507	138	90.58	Chlamydophila_psittaci_16S.l6.c4.ctg.1	167	9.7	0	.	n	.	0	G906T	SNP	906	906	G	72	72	T	10	T	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	194	Chlamydophila_psittaci_16S	1507	138	90.58	Chlamydophila_psittaci_16S.l6.c4.ctg.1	167	9.7	0	.	n	.	0	G908A	SNP	908	908	G	74	74	A	10	A	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	194	Chlamydophila_psittaci_16S	1507	138	90.58	Chlamydophila_psittaci_16S.l6.c4.ctg.1	167	9.7	0	.	n	.	0	A918T	SNP	918	918	A	84	84	T	12	T	12	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	194	Chlamydophila_psittaci_16S	1507	138	90.58	Chlamydophila_psittaci_16S.l6.c4.ctg.1	167	9.7	0	.	n	.	0	A943G	SNP	943	943	A	109	109	G	22	G	22	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	194	Chlamydophila_psittaci_16S	1507	138	90.58	Chlamydophila_psittaci_16S.l6.c4.ctg.1	167	9.7	0	.	n	.	0	G991T	SNP	991	991	G	157	157	T	15	T	15	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	1	SNP	p	L121Q	0	.	.	361	363	CTG	645	647	CTG	68;68;67	C;T;G	67;66;65	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	1	SNP	p	Q125E	0	.	.	373	375	CAG	657	659	CAG	63;64;63	C;A;G	63;63;61	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	1	SNP	p	Q125R	0	.	.	373	375	CAG	657	659	CAG	63;64;63	C;A;G	63;63;61	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	1	SNP	p	Q125K	0	.	.	373	375	CAG	657	659	CAG	63;64;63	C;A;G	63;63;61	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	1	SNP	p	Y161D	0	.	.	481	483	TAC	765	767	TAC	54;56;55	T;A;C	54;56;55	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	1	SNP	p	Y161N	0	.	.	481	483	TAC	765	767	TAC	54;56;55	T;A;C	54;56;55	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	1	SNP	p	Y161C	0	.	.	481	483	TAC	765	767	TAC	54;56;55	T;A;C	54;56;55	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1410	1412	GCA	41;41;44	G;C;A	40;37;41	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1410	1412	GCA	41;41;44	G;C;A	40;37;41	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1419	1421	GAA	46;46;48	G;A;A	46;45;47	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	0	HET	.	.	.	C954T	.	954	954	C	1238	1238	C	56	C,T	36,20	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	0	HET	.	.	.	C210T	.	210	210	C	494	494	C	59	C,T	30,28	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	187	1248	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1470	42.3	0	HET	.	.	.	C99T	.	99	99	C	383	383	C	35	C,T	21,14	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	478	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c30.ctg.1	1716	14.8	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1524	1526	AAA	5;2;2	A;A;A	5;2;2	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	598	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1598	19.7	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1245	1247	GAA	29;28;29	G;A;A	29;28;29	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	142	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	712	10.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	C990G	SNP	990	990	C	50	50	G	30	G	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1002A	SNP	1002	1002	T	62	62	A	28	A	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	A1003C	SNP	1003	1003	A	63	63	C	28	C	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	G1008C	SNP	1008	1008	G	68	68	C	27	C,G	17,10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	C1011T	SNP	1011	1011	C	71	71	T	27	T	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1012C	SNP	1012	1012	T	72	72	C	27	C,T	16,11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	C1023A	SNP	1023	1023	C	82	82	A	36	A	29	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	.1025G	INS	1025	1025	T	85	85	G	29	G	29	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1041G	SNP	1041	1041	T	101	101	G	82	G	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	A1042T	SNP	1042	1042	A	102	102	T	86	T	86	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	A1136G	SNP	1136	1136	A	196	196	G	99	G	98	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1138C	SNP	1138	1138	T	198	198	C	95	C	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1142C	SNP	1142	1142	T	202	202	C	93	C	93	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	C1170T	SNP	1170	1170	C	230	230	T	85	T	85	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1220C	SNP	1220	1220	T	280	280	C	100	C	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1245C	SNP	1245	1245	T	305	305	C	70	C	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	G1253A	SNP	1253	1253	G	313	313	A	76	A	76	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	G1256A	SNP	1256	1256	G	316	316	A	78	A	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	C1258A	SNP	1258	1258	C	318	318	A	80	A	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	G1266T	SNP	1266	1266	G	326	326	T	74	T	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1267C	SNP	1267	1267	T	327	327	C	71	C	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1275C	SNP	1275	1275	T	335	335	C	64	C	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	G1276A	SNP	1276	1276	G	336	336	A	65	A	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	A1281G	SNP	1281	1281	A	341	341	G	65	G	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1283C	SNP	1283	1283	T	343	343	C	68	C	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	G1288T	SNP	1288	1288	G	348	348	T	72	T	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	A1296G	SNP	1296	1296	A	356	356	G	96	G	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1299G	SNP	1299	1299	T	359	359	G	102	G	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	A1300T	SNP	1300	1300	A	360	360	T	105	T	105	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	C1356T	SNP	1356	1356	C	416	416	T	106	T	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	A1358G	SNP	1358	1358	A	418	418	G	101	G	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1368C	SNP	1368	1368	T	428	428	C	79	C	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	G1370A	SNP	1370	1370	G	430	430	A	71	A	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	C1406.	DEL	1406	1406	C	465	465	C	31	C	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	.1409C	INS	1409	1409	T	469	469	C	28	C	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	C1431A	SNP	1431	1431	C	491	491	A	5	A	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	C1432A	SNP	1432	1432	C	492	492	A	5	A	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	A1441G	SNP	1441	1441	A	501	501	G	6	G	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	T1464C	SNP	1464	1464	T	524	524	C	20	C	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	G1473T	SNP	1473	1473	G	533	533	T	37	T	36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	A1475G	SNP	1475	1475	A	535	535	G	41	G	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	.	n	.	0	A1548T	SNP	1548	1548	A	608	608	T	36	T	36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	1	SNP	n	C1194G	0	.	.	1194	1194	C	254	254	C	90	C	90	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1684	Pasteurella_multocida_16S	1551	611	90.86	Pasteurella_multocida_16S.l6.c30.ctg.1	874	55.3	0	HET	.	.	.	C1040T	.	1040	1040	T	100	100	C	76	C,T	48,28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	474	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1546	16.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	232	234	CGT	15;15;15	C;G;T	15;15;15	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	474	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1546	16.0	0	.	p	.	0	V30I	NONSYN	88	90	GTC	316	318	ATC	17;17;17	A;T;C	17;17;17	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	474	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1546	16.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1075	1077	GGC	20;19;19	G;G;C	20;19;19	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	614	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2000	16.4	0	.	p	.	0	R8S	NONSYN	22	24	AGA	182	184	AGC	4;4;4	A;G;C	4;4;4	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	614	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2000	16.4	0	.	p	.	0	I142L	NONSYN	424	426	ATA	584	586	CTA	13;13;13	C;T,A;A	12;12,1;13	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	614	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2000	16.4	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1103	1105	CAA	22;22;24	C;A;A	21;22;23	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	614	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2000	16.4	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1202	1204	GGT	34;36;37	G;G;T	34;36;37	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	614	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2000	16.4	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1772	1774	GTT	9;9;9	G;T;T	9;9;9	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	515	270	PmrE	1167	1056	96.69	PmrE.l6.c4.ctg.1	1245	10.0	0	.	p	.	0	A125E	NONSYN	373	375	GCA	562	564	GAA	6;5;5	G;A;A	6;5;5	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	515	270	PmrE	1167	1056	96.69	PmrE.l6.c4.ctg.1	1245	10.0	0	.	p	.	0	M185T	NONSYN	553	555	ATG	742	744	ACC	4;4;4	A;C;C	4;4;4	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	515	270	PmrE	1167	1056	96.69	PmrE.l6.c4.ctg.1	1245	10.0	0	.	p	.	0	S225T	NONSYN	673	675	TCC	862	864	ACT	11;11;11	A;C;T	11;11;11	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	515	270	PmrE	1167	111	98.2	PmrE.l6.c4.ctg.2	183	8.0	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	7	9	ATC	6;7;7	A;T;C	6;6;7	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	424	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1385	16.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	40	TEM_1+	858	103	99.03	TEM_1+.l15.c30.ctg.1	139	2.3	0	.	p	.	0	F19L	NONSYN	55	57	TTT	91	93	CTT	4;4;4	C;T;T	4;4;4	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	40	TEM_1+	858	174	100.0	TEM_1+.l15.c30.ctg.2	174	2.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	378	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1210	16.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1232	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3317	19.5	0	.	p	.	0	T85I	NONSYN	253	255	ACC	360	362	ATC	15;15;15	A;T;C	15;15;15	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1232	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3317	19.5	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2073	2075	AAG	10;10;11	A;A;G	10;10;11	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	458	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1535	15.6	0	.	p	.	0	A22V	NONSYN	64	66	GCC	273	275	GTC	6;6;6	G;T;C	6;6;6	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	458	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1535	15.6	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1014	1016	TGC	28;27;28	T;G;C	28;27;28	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1070	acrF	3105	2598	98.5	acrF.l15.c17.ctg.1	2817	19.7	0	.	p	.	0	S46trunc	TRUNC	136	136	T	200	200	T	9	T	9	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1070	acrF	3105	2598	98.5	acrF.l15.c17.ctg.1	2817	19.7	0	.	p	.	0	G148D	NONSYN	442	444	GGC	506	508	GAC	21;21;19	G;A;C	21;21;19	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1070	acrF	3105	2598	98.5	acrF.l15.c17.ctg.1	2817	19.7	0	.	p	.	0	F240L	NONSYN	718	720	TTT	782	784	TTA	9;9;9	T;T;A	9;9;9	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1070	acrF	3105	2598	98.5	acrF.l15.c17.ctg.1	2817	19.7	0	.	p	.	0	D301N	NONSYN	901	903	GAT	965	967	AAT	15;16;16	A;A;T	15;16;16	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1070	acrF	3105	2598	98.5	acrF.l15.c17.ctg.1	2817	19.7	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1752	1752	T	31	T	31	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	264	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	974	14.4	1	SNP	p	R45C	0	.	.	133	135	CGC	342	344	CGC	25;25;25	C;G;C	24;25;25	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	202	acrS	663	663	98.64	acrS.l15.c4.ctg.1	873	12.0	0	.	p	.	0	L34F	NONSYN	100	102	CTC	115	117	TTC	9;9;9	T;T;C	9;9;9	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	202	acrS	663	663	98.64	acrS.l15.c4.ctg.1	873	12.0	0	.	p	.	0	E122G	NONSYN	364	366	GAG	379	381	GGG	15;15;14	G;G;G	15;15;14	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	254	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1087	11.9	0	.	p	.	0	V136L	NONSYN	406	408	GTT	478	480	CTT	13;13;14	C;T;T	13;13;14	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1292	alaS	2631	2631	98.86	alaS.l6.c4.ctg.1	2993	23.0	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2019	2021	GCA	37;38;37	G;C;A	37;38;37	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1292	alaS	2631	2631	98.86	alaS.l6.c4.ctg.1	2993	23.0	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2280	2282	ACC	31;31;32	A;C;C	30;31;32	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1292	alaS	2631	2631	98.86	alaS.l6.c4.ctg.1	2993	23.0	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2589	2591	GCC	26;26;25	G;C;C	26;25;25	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	562	arnA_1	1983	1547	98.64	arnA_1.l15.c4.ctg.1	1767	14.5	0	.	p	.	0	I150V	NONSYN	448	450	ATT	12	14	GTT	3;3;4	G;T;T	3;3;4	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	562	arnA_1	1983	1547	98.64	arnA_1.l15.c4.ctg.1	1767	14.5	0	.	p	.	0	R200H	NONSYN	598	600	CGC	162	164	CAC	18;18;18	C;A;C	18;18;18	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	562	arnA_1	1983	1547	98.64	arnA_1.l15.c4.ctg.1	1767	14.5	0	.	p	.	0	T295M	NONSYN	883	885	ACG	447	449	ATG	20;20;21	A;T;G	20;20;21	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	562	arnA_1	1983	1547	98.64	arnA_1.l15.c4.ctg.1	1767	14.5	0	.	p	.	0	Y463S	NONSYN	1387	1389	TAT	951	953	TCT	1;1;1	T;C,A;T	1;0,1;1	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	562	arnA_1	1983	1547	98.64	arnA_1.l15.c4.ctg.1	1767	14.5	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1443	1445	CGC	14;13;13	C;G;C	14;13;13	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	562	arnA_1	1983	367	96.46	arnA_1.l15.c4.ctg.2	367	9.1	0	.	p	.	0	G37A	NONSYN	109	111	GGT	36	38	GCT	6;7;7	G;C;T	6;7;7	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	562	arnA_1	1983	367	96.46	arnA_1.l15.c4.ctg.2	367	9.1	0	.	p	.	0	D77E	NONSYN	229	231	GAT	156	158	GAG	1;1;1	G;A;G	1;1;1	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	562	arnA_1	1983	367	96.46	arnA_1.l15.c4.ctg.2	367	9.1	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	192	194	TGC	3;3;4	T;G;C	3;3;4	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	246	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1114	11.4	0	.	p	.	0	S221T	NONSYN	661	663	AGC	824	826	ACC	12;12;12	A;C;C	12;12;12	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	246	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1114	11.4	0	.	p	.	0	P225S	NONSYN	673	675	CCG	836	838	TCG	10;10;10	T;C;G	10;10;10	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	248	baeR	723	723	97.79	baeR.l6.c30.ctg.1	1124	11.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	512	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1549	16.7	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1263	1265	AAA	5;5;5	A;A;A	5;5;5	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	512	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1549	16.7	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1275	1277	GAG	4;4;4	G;A;G	4;4;4	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	512	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1549	16.7	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1281	1283	CAC	4;4;5	C;A;C	4;4;5	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	512	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1549	16.7	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1335	1337	GAG	10;10;9	G;A;G	10;10;9	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	618	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1814	18.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	350	cpxR	699	699	99.43	cpxR.l6.c4.ctg.1	1063	17.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	356	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1258	14.8	0	.	p	.	0	A146T	NONSYN	436	438	GCT	597	599	ACT	17;17;17	A;C;T	17;17;17	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	160	dfrA1_1	474	474	100.0	dfrA1_1.l6.c30.ctg.1	858	10.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	524	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1542	18.0	0	.	p	.	0	I219V	NONSYN	655	657	ATC	782	784	GTC	36;36;36	G,A;T;C	34,1;35;36	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	700	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	1939	19.3	0	.	p	.	0	E197K	NONSYN	589	591	GAA	803	805	AAA	21;22;22	A;A;A	21;22;22	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	484	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1449	17.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	827	829	AGC	12;10;9	A;G;C	12;10;9	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	0	20	emrE_1	333	91	96.7	emrE_1.l6.c4.ctg.1	91	5.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	0	20	emrE_1	333	133	92.48	emrE_1.l6.c4.ctg.2	133	2.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	310	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1320	12.1	0	.	p	.	0	K176R	NONSYN	526	528	AAG	589	591	AGG	11;11;11	A;G;G	11;11;11	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	310	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1320	12.1	0	.	p	.	0	N306D	NONSYN	916	918	AAC	979	981	GAC	4;4;5	G;A;C	4;4;5	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	242	emrR	531	531	100.0	emrR.l15.c4.ctg.1	943	13.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	454	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1791	12.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	164	evgA	615	615	99.19	evgA.l6.c30.ctg.1	744	10.4	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	257	259	CTG	12;12;12	C;T;G	12;12;12	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	870	97.36	evgS.l6.c30.ctg.1	935	10.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	177	179	ATA	4;4;4	A;T;A	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	870	97.36	evgS.l6.c30.ctg.1	935	10.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	189	191	GTA	3;3;3	G;T;A	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	870	97.36	evgS.l6.c30.ctg.1	935	10.6	0	.	p	.	0	A93T	NONSYN	277	279	GCG	342	344	ACG	9;9;8	A;C;G	9;9;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	870	97.36	evgS.l6.c30.ctg.1	935	10.6	0	.	p	.	0	A114E	NONSYN	340	342	GCA	405	407	GAA	10;11;11	G;A;A	10;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	870	97.36	evgS.l6.c30.ctg.1	935	10.6	0	.	p	.	0	T127A	NONSYN	379	381	ACT	444	446	GCT	12;11;11	G;C;T	12;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	870	97.36	evgS.l6.c30.ctg.1	935	10.6	0	.	p	.	0	N133D	NONSYN	397	399	AAT	462	464	GAT	10;10;10	G;A;T	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	870	97.36	evgS.l6.c30.ctg.1	935	10.6	0	.	p	.	0	P162S	NONSYN	484	486	CCA	549	551	TCA	8;7;7	T;C;A	8;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	870	97.36	evgS.l6.c30.ctg.1	935	10.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	678	680	CAG	5;5;7	C;A;G	5;5;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	870	97.36	evgS.l6.c30.ctg.1	935	10.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	816	818	GTT	6;6;6	G;T;T	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	53	55	AAT	7;7;6	A;A;T	7;7;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	74	76	TTA	1;1;1	T;T;A	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	275	277	AAA	4;4;4	A;A;A	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	1010	1012	CAT	8;8;8	C;A;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	1064	1066	CAT	4;4;4	C;A;T	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1082	1084	AGA	7;8;8	A;G;A	7;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1097	1099	AAT	10;10;10	A;A;T	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1244	1246	TCC	4;4;4	T;C;C	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1409	1411	ATT	13;13;12	A;T;T	13;13;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1430	1432	GAT	8;8;8	G;A;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1544	1546	GTT	12;13;11	G;T;T	12;13;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	890	evgS	3594	2572	97.63	evgS.l6.c30.ctg.2	2651	13.4	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1829	1831	CAC	16;17;17	C;A;C	16;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	322	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1291	13.2	1	SNP	p	P64H	0	.	.	190	192	CCA	437	439	CCA	32;33;32	C;C;A	32;33;32	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	322	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1291	13.2	1	SNP	p	P64A	0	.	.	190	192	CCA	437	439	CCA	32;33;32	C;C;A	32;33;32	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	322	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1291	13.2	1	SNP	p	P64L	0	.	.	190	192	CCA	437	439	CCA	32;33;32	C;C;A	32;33;32	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	322	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1291	13.2	1	SNP	p	P64S	0	.	.	190	192	CCA	437	439	CCA	32;33;32	C;C;A	32;33;32	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	322	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1291	13.2	1	SNP	p	P64R	0	.	.	190	192	CCA	437	439	CCA	32;33;32	C;C;A	32;33;32	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	112	gadE	528	528	100.0	gadE.l6.c4.ctg.1	887	6.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	38	gadW	729	147	97.28	gadW.l15.c4.ctg.1	147	6.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	38	gadW	729	151	94.7	gadW.l15.c4.ctg.3	151	4.3	0	.	p	.	0	K110N	NONSYN	328	330	AAA	23	25	AAT	3;3;3	A;A;T	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	160	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1020	8.3	0	.	p	.	0	F53L	NONSYN	157	159	TTC	312	314	TTA	12;12;12	T;T;A	12;12;12	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	160	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1020	8.3	0	.	p	.	0	V79I	NONSYN	235	237	GTT	390	392	ATT	3;3;3	A;T;T	3;3;3	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	160	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1020	8.3	0	.	p	.	0	R246G	NONSYN	736	738	AGA	891	893	GGA	10;10;11	G;G;A	10;10;11	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	160	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1020	8.3	0	.	p	.	0	S248P	NONSYN	742	744	TCG	897	899	CCG	10;10;10	C;C;G	10;10;10	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1396	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3072	24.0	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2271	2273	GAA	37;37;37	G;A;A	37;37;36	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1396	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3072	24.0	1	SNP	p	S83W	0	.	.	247	249	TCG	486	488	TCG	33;33;34	T;C;G	33;33;34	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1396	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3072	24.0	1	SNP	p	S83L	0	.	.	247	249	TCG	486	488	TCG	33;33;34	T;C;G	33;33;34	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1396	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3072	24.0	1	SNP	p	S83I	0	.	.	247	249	TCG	486	488	TCG	33;33;34	T;C;G	33;33;34	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1396	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3072	24.0	1	SNP	p	D87Y	0	.	.	259	261	GAC	498	500	GAC	32;31;31	G;A;C	32;31;31	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1396	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3072	24.0	1	SNP	p	D87V	0	.	.	259	261	GAC	498	500	GAC	32;31;31	G;A;C	32;31;31	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1396	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3072	24.0	1	SNP	p	D87N	0	.	.	259	261	GAC	498	500	GAC	32;31;31	G;A;C	32;31;31	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1396	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3072	24.0	1	SNP	p	D87G	0	.	.	259	261	GAC	498	500	GAC	32;31;31	G;A;C	32;31;31	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1396	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3072	24.0	1	SNP	p	D87H	0	.	.	259	261	GAC	498	500	GAC	32;31;31	G;A;C	32;31;31	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1004	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2625	19.9	1	SNP	p	R136E	0	.	.	406	408	CGC	601	603	CGC	18;18;18	C;G;C	17;18;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1004	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2625	19.9	1	SNP	p	R136I	0	.	.	406	408	CGC	601	603	CGC	18;18;18	C;G;C	17;18;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1004	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2625	19.9	1	SNP	p	R136G	0	.	.	406	408	CGC	601	603	CGC	18;18;18	C;G;C	17;18;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1004	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2625	19.9	1	SNP	p	R136H	0	.	.	406	408	CGC	601	603	CGC	18;18;18	C;G;C	17;18;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1004	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2625	19.9	1	SNP	p	R136L	0	.	.	406	408	CGC	601	603	CGC	18;18;18	C;G;C	17;18;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1004	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2625	19.9	1	SNP	p	R136S	0	.	.	406	408	CGC	601	603	CGC	18;18;18	C;G;C	17;18;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1004	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2625	19.9	1	SNP	p	R136C	0	.	.	406	408	CGC	601	603	CGC	18;18;18	C;G;C	17;18;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	234	kdpE	678	678	98.23	kdpE.l15.c4.ctg.2	826	14.2	0	.	p	.	0	A72P	NONSYN	214	216	GCG	281	283	CCG	21;24;23	C;C;G	21;24;23	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	234	kdpE	678	678	98.23	kdpE.l15.c4.ctg.2	826	14.2	0	.	p	.	0	T123A	NONSYN	367	369	ACC	434	436	GCC	14;14;13	G;C;C	13;13;12	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	430	leuO	945	945	99.26	leuO.l6.c4.ctg.1	1226	18.6	0	.	p	.	0	P9S	NONSYN	25	27	CCA	130	132	TCA	17;16;15	T;C;A	17;16;15	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	188	marA	384	384	99.74	marA.l6.c30.ctg.1	715	13.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	348	350	AGC	9;9;9	A;G;C	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	450	452	CAT	3;3;3	C;A;T	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	V45E	0	.	.	133	135	GTG	174	176	GTG	13;13;13	G;T;G	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	I49S	0	.	.	145	147	ATC	186	188	ATC	10;9;9	A;T;C	10;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	A70T	0	.	.	208	210	GCA	249	251	GCA	8;8;7	G;C;A	8;8;7	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	R73S	0	.	.	217	219	CGT	258	260	CGT	8;7;7	C;G;T	8;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	R73C	0	.	.	217	219	CGT	258	260	CGT	8;7;7	C;G;T	8;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	R77L	0	.	.	229	231	CGC	270	272	CGC	8;8;8	C;G;C	8;8;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	R77C	0	.	.	229	231	CGC	270	272	CGC	8;8;8	C;G;C	8;8;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	L78M	0	.	.	232	234	CTG	273	275	CTG	8;8;8	C;T;G	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	R94H	0	.	.	280	282	CGC	321	323	CGC	9;9;9	C;G;C	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	R94S	0	.	.	280	282	CGC	321	323	CGC	9;9;9	C;G;C	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.7	marR.l15.c30.ctg.1	524	6.6	1	SNP	p	V96E	0	.	.	286	288	GTA	327	329	GTA	9;9;9	G;T;A	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	336	mdfA	1233	1206	97.01	mdfA.l6.c4.ctg.1	1400	12.3	0	.	p	.	0	R36I	NONSYN	106	108	AGG	79	81	ATC	7;7;7	A;T;C	7;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	336	mdfA	1233	1206	97.01	mdfA.l6.c4.ctg.1	1400	12.3	0	.	p	.	0	E42A	NONSYN	124	126	GAA	97	99	GCC	3;3;3	G;C;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	336	mdfA	1233	1206	97.01	mdfA.l6.c4.ctg.1	1400	12.3	0	.	p	.	0	N43V	NONSYN	127	129	AAT	100	102	GTG	4;4;4	G;T;G	4;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	336	mdfA	1233	1206	97.01	mdfA.l6.c4.ctg.1	1400	12.3	0	.	p	.	0	E52D	NONSYN	154	156	GAG	127	129	GAT	5;5;5	G;A;T	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	336	mdfA	1233	1206	97.01	mdfA.l6.c4.ctg.1	1400	12.3	0	.	p	.	0	N59T	NONSYN	175	177	AAC	148	150	ACC	5;5;5	A;C;C	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	336	mdfA	1233	1206	97.01	mdfA.l6.c4.ctg.1	1400	12.3	0	.	p	.	0	I68L	NONSYN	202	204	ATA	175	177	TTA	4;4;4	T;T;A	3;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	336	mdfA	1233	1206	97.01	mdfA.l6.c4.ctg.1	1400	12.3	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	316	318	CAG	21;19;19	C;A;G	21;19;19	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	336	mdfA	1233	1206	97.01	mdfA.l6.c4.ctg.1	1400	12.3	0	.	p	.	0	D128A	NONSYN	382	384	GAC	355	357	GCC	15;15;14	G;C;C	15;15;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	336	mdfA	1233	1206	97.01	mdfA.l6.c4.ctg.1	1400	12.3	0	.	p	.	0	S163A	NONSYN	487	489	TCG	460	462	GCG	11;12;13	G;C;G	11;12;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	336	mdfA	1233	1206	97.01	mdfA.l6.c4.ctg.1	1400	12.3	0	.	p	.	0	L231V	NONSYN	691	693	CTT	664	666	GTT	8;7;7	G;T;T	7;5;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	336	mdfA	1233	1206	97.01	mdfA.l6.c4.ctg.1	1400	12.3	0	.	p	.	0	R285fs	FSHIFT	853	853	C	826	826	C	11	C	11	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	400	mdtA	1248	980	97.76	mdtA.l15.c4.ctg.1	1216	14.6	0	.	p	.	0	I99M	NONSYN	295	297	ATA	27	29	ATG	3;3;3	A;T;G	3;3;3	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	400	mdtA	1248	980	97.76	mdtA.l15.c4.ctg.1	1216	14.6	0	.	p	.	0	A130T	NONSYN	388	390	GCC	120	122	ACC	8;8;8	A;C;C	7;8;8	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	400	mdtA	1248	980	97.76	mdtA.l15.c4.ctg.1	1216	14.6	0	.	p	.	0	P257T	NONSYN	769	771	CCG	501	503	ACG	10;10;10	A;C;G	10;10;10	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	400	mdtA	1248	274	95.62	mdtA.l15.c4.ctg.2	288	9.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	54	54	G	14	G	14	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	400	mdtA	1248	274	95.62	mdtA.l15.c4.ctg.2	288	9.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	111	113	CAG	8;6;6	C;A;G	8;6;5	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	400	mdtA	1248	274	95.62	mdtA.l15.c4.ctg.2	288	9.7	0	.	p	.	0	A48V	NONSYN	142	144	GCG	156	158	GTG	13;13;13	G;T;G	13;13;13	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	400	mdtA	1248	274	95.62	mdtA.l15.c4.ctg.2	288	9.7	0	.	p	.	0	T83I	NONSYN	247	249	ACC	261	263	ATC	8;6;6	A;T;C	8;6;6	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1444	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3491	22.0	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1950	1952	ACC	21;19;19	A;C;C	21;19;19	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1444	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3491	22.0	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2343	2345	CAA	18;19;21	C;A;A	17;18;19	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1444	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3491	22.0	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2511	2513	ATT	19;19;20	A;T;T	19;19;20	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1444	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3491	22.0	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2595	2597	GTT	13;12;12	G;T;T	13;12;12	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1444	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3491	22.0	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2703	2705	GAG	18;18;16	G;A;G	18;17;16	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1444	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3491	22.0	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2931	2933	ATG	14;14;14	A;T;G	14;14;14	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1444	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3491	22.0	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3066	3068	GAT	16;17;18	G;A;T	16;17;18	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1302	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3287	20.8	0	.	p	.	0	I46M	NONSYN	136	138	ATC	323	325	ATG	14;13;13	A;T;G	14;13;13	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1302	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3287	20.8	0	.	p	.	0	V208I	NONSYN	622	624	GTC	809	811	ATC	25;25;25	A;T;C	25;24;25	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1302	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3287	20.8	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3125	3127	CAC	5;5;4	C;A;C	5;5;4	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1302	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3287	20.8	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3128	3130	CTC	4;4;4	C;T;C	4;4;4	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	572	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1920	15.9	0	.	p	.	0	D3E	NONSYN	7	9	GAT	292	294	GAA	9;9;9	G;A;A	9;9;9	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	572	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1920	15.9	0	.	p	.	0	T226A	NONSYN	676	678	ACG	961	963	GCG	15;15;15	G;C;G	15;15;15	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	572	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1920	15.9	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1303	1305	ATC	18;19;20	A;T;C	16;18;19	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	572	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1920	15.9	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1606	1608	TTT	19;21;21	T;T;T	19;20;21	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	556	mdtE	1158	1158	99.31	mdtE.l6.c4.ctg.1	1543	19.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1306	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3529	19.7	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1073	1075	ACC	15;14;14	A;C;C	15;14;14	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1306	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3529	19.7	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2315	2317	GAC	31;31;31	G;A;C	29;31;29	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	528	98	mdtG	1227	182	99.45	mdtG.l6.c30.ctg.1	559	8.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	167	169	GGA	2;2;2	G;G;A	2;2;2	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	420	mdtH	1209	1202	98.17	mdtH.l15.c30.ctg.1	1351	16.1	0	.	p	.	0	G134C	NONSYN	400	402	GGT	393	395	TGT	21;23;23	T;G;T	21;23;23	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	420	mdtH	1209	1202	98.17	mdtH.l15.c30.ctg.1	1351	16.1	0	.	p	.	0	S324L	NONSYN	970	972	TCG	963	965	TTG	12;12;11	T;T;G	12;12;11	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	420	mdtH	1209	1202	98.17	mdtH.l15.c30.ctg.1	1351	16.1	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1173	1175	ACG	12;12;12	A;C;G	12;12;12	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	492	mdtL	1176	1176	98.38	mdtL.l6.c30.ctg.1	1558	16.6	0	.	p	.	0	A185S	NONSYN	553	555	GCC	710	712	TCC	6;7;8	T;C;C	6;7;8	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	362	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1384	14.0	0	.	p	.	0	V119I	NONSYN	355	357	GTT	503	505	ATT	15;14;14	A;T;T	15;14;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2432	16.7	0	.	p	.	0	V11M	NONSYN	31	33	GTG	199	201	ATG	9;11;11	A;T;G	9;11;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2432	16.7	0	.	p	.	0	T33I	NONSYN	97	99	ACC	265	267	ATC	15;15;15	A;T;C	15;15;15	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2432	16.7	0	.	p	.	0	C116R	NONSYN	346	348	TGC	514	516	CGC	18;18;18	C;G;C	18;18;18	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2432	16.7	0	.	p	.	0	N238S	NONSYN	712	714	AAC	880	882	AGC	11;11;10	A;G;C	11;10;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2432	16.7	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1081	1083	GTG	14;14;15	G;T;G	14;14;15	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2432	16.7	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1144	1146	AAC	7;7;8	A;A;C	5;5;7	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2432	16.7	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1189	1191	GTC	12;12;13	G;T;C	12;12;13	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2432	16.7	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1219	1221	ATA	20;20;18	A;T;A	20;20;18	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2432	16.7	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1327	1329	TCT	10;10;11	T;C;T	10;10;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2432	16.7	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1714	1716	GCG	9;10;10	G;C;G	9;10;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	770	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2432	16.7	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1927	1929	ATC	13;12;12	A;T;C	13;12;12	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	516	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1738	15.5	0	.	p	.	0	S129A	NONSYN	385	387	TCA	450	452	GCG	13;14;13	G;C;G	13;14;13	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	516	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1738	15.5	0	.	p	.	0	A187T	NONSYN	559	561	GCC	624	626	ACC	11;12;12	A;C;C	11;11;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	516	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1738	15.5	0	.	p	.	0	H211R	NONSYN	631	633	CAC	696	698	CGC	25;26;25	C;G;C	25;26;25	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	516	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1738	15.5	0	.	p	.	0	V250A	NONSYN	748	750	GTT	813	815	GCT	9;11;12	G;C;T	9;11;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	516	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1738	15.5	0	.	p	.	0	R278K	NONSYN	832	834	AGA	897	899	AAA	13;13;12	A;A;A	13;13;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	516	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1738	15.5	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	915	917	CGA	15;15;17	C;G;A	15;15;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	516	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1738	15.5	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1080	1082	GCC	10;10;11	G;C;C	10;10;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	516	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1738	15.5	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1092	1094	GAT	12;12;12	G;A;T	12;12;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	516	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1738	15.5	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1509	1511	GCT	2;2;2	G;C;T	2;2;2	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1418	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3827	19.6	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1507	1509	AAG	16;16;16	A;A;G	16;16;16	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1418	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3827	19.6	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2584	2586	CTG	29;31;30	C;T,G;G	29;30,1;30	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	86	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	164	14.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	940	msbA	1749	1749	98.68	msbA.l15.c17.ctg.1	2127	23.6	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1009	1011	AAC	22;22;23	A;A;C	22;22;23	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	940	msbA	1749	1749	98.68	msbA.l15.c17.ctg.1	2127	23.6	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1555	1557	ATA	32;33;32	A;T;A	32;33;32	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	568	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1642	18.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1299	1301	GAT	24;24;23	G;A;T	24;24;23	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	568	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1642	18.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1302	1304	CTG	25;25;24	C;T;G	25;25;24	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1052	10.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	223	225	TGT	11;11;10	T;G;T	11;10;10	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1052	10.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	493	495	ACC	11;11;14	A;C;C	11;11;14	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1052	10.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	703	705	GAC	14;15;14	G;A;C	14;15;14	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1052	10.0	1	SNP	p	R15C	0	.	.	43	45	CGC	187	189	CGC	15;15;15	C;G;C	15;15;15	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1052	10.0	1	SNP	p	S33R	0	.	.	97	99	AGC	241	243	AGC	8;8;9	A;G;C	8;8;9	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1052	10.0	1	SNP	p	G131D	0	.	.	391	393	GGC	535	537	GGC	14;15;15	G;G;C	14;15;14	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1052	10.0	1	SNP	p	R203C	0	.	.	607	609	CGT	751	753	CGT	9;8;8	C;G;T	9;8;8	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1052	10.0	1	SNP	p	R203L	0	.	.	607	609	CGT	751	753	CGT	9;8;8	C;G;T	9;8;8	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	544	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1148	23.2	0	.	p	.	0	D312E	NONSYN	934	936	GAT	947	949	GAG	21;19;18	G;A;G	21;19;18	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	544	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1148	23.2	1	SNP	p	G141D	0	.	.	421	423	GGT	434	436	GGT	41;40;38	G;G;T	41;40;38	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	544	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1148	23.2	1	SNP	p	G141E	0	.	.	421	423	GGT	434	436	GGT	41;40;38	G;G;T	41;40;38	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	544	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1148	23.2	1	SNP	p	R154A	0	.	.	460	462	CGT	473	475	CGT	22;21;21	C;G;T	22;21;21	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	544	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1148	23.2	1	SNP	p	R154D	0	.	.	460	462	CGT	473	475	CGT	22;21;21	C;G;T	22;21;21	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1066	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	21.3	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1799	1801	GTG	27;27;27	G;T;G	27;27;27	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1066	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	21.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1826	1828	TCG	27;29;27	T;C;G	24;27;26	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1066	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	21.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2441	2443	AAC	10;11;11	A;A;C	10;11;11	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1066	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	21.3	1	SNP	p	A85T	0	.	.	253	255	GCG	455	457	GCG	22;22;20	G;C;G	21;22;19	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1066	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	21.3	1	SNP	p	D111H	0	.	.	331	333	GAT	533	535	GAT	11;11;10	G;A;T	11;10;10	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1066	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	21.3	1	SNP	p	S129P	0	.	.	385	387	TCC	587	589	TCC	26;26;27	T;C;C	26;26;27	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	584	parE_1	1893	1893	97.36	parE_1.l6.c4.ctg.1	2167	13.8	0	.	p	.	0	R54S	NONSYN	160	162	CGC	215	217	AGC	3;5;5	A;G;C	0;1;2	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	584	parE_1	1893	1893	97.36	parE_1.l6.c4.ctg.1	2167	13.8	0	.	p	.	0	V55G	NONSYN	163	165	GTG	218	220	GGG	5;5;5	G;G,T;G	1;0,1;2	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	584	parE_1	1893	1893	97.36	parE_1.l6.c4.ctg.1	2167	13.8	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1472	1474	AAC	23;23;23	A;A;C	23;23;23	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	584	parE_1	1893	1893	97.36	parE_1.l6.c4.ctg.1	2167	13.8	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1481	1483	GAT	24;24;25	G;A;T	24;24;25	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	648	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1845	18.5	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	834	836	CAG	19;17;17	C;A;G	19;17;17	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	648	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1845	18.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1308	1310	GAT	24;23;23	G;A;T	23;22;23	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1920	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4442	23.1	1	SNP	p	V146F	0	.	.	436	438	GTT	657	659	GTT	16;16;16	G;T;T	16;16;16	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1920	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4442	23.1	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1758	1760	CAG	28;26;25	C;A;G	28;26;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1920	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4442	23.1	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1758	1760	CAG	28;26;25	C;A;G	28;26;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1920	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4442	23.1	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1797	1799	CAC	19;20;22	C;A,C;C	19;19,1;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1920	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4442	23.1	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1806	1808	CGT	22;21;21	C;G;T	22;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1920	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4442	23.1	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1806	1808	CGT	22;21;21	C;G;T	22;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1920	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4442	23.1	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1812	1814	TCC	21;21;21	T;C;C	21;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1920	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4442	23.1	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1818	1820	CTC	17;17;17	C;T;C	16;17;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1920	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4442	23.1	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1908	1910	ACC	18;18;18	A;C;C	18;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1920	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4442	23.1	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1911	1913	CCT	17;17;17	C;C;T	17;17;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1920	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4442	23.1	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2280	2282	CGT	32;33;33	C;G;T	32;33;33	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	0	.	n	.	0	A226G	SNP	226	226	A	300	300	G	169	G	168	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	1	SNP	n	A794T	0	.	.	794	794	A	868	868	A	128	A	126	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	1	SNP	n	A794G	0	.	.	794	794	A	868	868	A	128	A	126	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	1	SNP	n	G926A	0	.	.	926	926	G	1000	1000	G	154	G	154	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	1	SNP	n	G926C	0	.	.	926	926	G	1000	1000	G	154	G	154	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	1	SNP	n	G926T	0	.	.	926	926	G	1000	1000	G	154	G	154	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	0	HET	.	.	.	C183T	.	183	183	C	257	257	C	109	C,T	74,35	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	0	HET	.	.	.	A250T	.	250	250	A	324	324	A	170	A,T	132,38	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	0	HET	.	.	.	T90C	.	90	90	T	164	164	T	114	T,C	85,29	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	0	HET	.	.	.	G474A	.	474	474	G	548	548	G	163	G,A	123,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	0	HET	.	.	.	A253T	.	253	253	A	327	327	A	177	A,T	139,38	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	0	HET	.	.	.	C194T	.	194	194	C	268	268	C	119	C,T	91,28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	0	HET	.	.	.	C719T	.	719	719	C	793	793	C	157	C,T	89,68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	0	HET	.	.	.	A79G	.	79	79	A	153	153	A	112	A,G	80,26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1075	137.7	0	HET	.	.	.	T273A	.	273	273	T	347	347	T	155	T,A	118,35	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	519	100.0	rrsB+.l15.c17.ctg.2	532	168.3	1	SNP	n	A1519G	0	.	.	1519	1519	A	496	496	A	94	A	94	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	519	100.0	rrsB+.l15.c17.ctg.2	532	168.3	1	SNP	n	A1519T	0	.	.	1519	1519	A	496	496	A	94	A	94	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	519	100.0	rrsB+.l15.c17.ctg.2	532	168.3	1	SNP	n	A1519C	0	.	.	1519	1519	A	496	496	A	94	A	94	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	519	100.0	rrsB+.l15.c17.ctg.2	532	168.3	0	HET	.	.	.	C1038T	.	1038	1038	C	15	15	C	101	C,T	40,14	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	128	100.0	rrsB+.l15.c17.ctg.3	128	24.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	121	95.08	rrsB+.l15.c17.ctg.4	121	23.6	0	.	n	.	0	G1002A	SNP	1002	1002	G	51	51	A	44	A	44	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	121	95.08	rrsB+.l15.c17.ctg.4	121	23.6	0	.	n	.	0	G1006C	SNP	1006	1006	G	55	55	C	44	C	44	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	121	95.08	rrsB+.l15.c17.ctg.4	121	23.6	0	.	n	.	0	T1010C	SNP	1010	1010	T	59	59	C	41	C	41	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	121	95.08	rrsB+.l15.c17.ctg.4	121	23.6	0	.	n	.	0	A1019.	DEL	1019	1019	A	67	67	G	42	G	42	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	121	95.08	rrsB+.l15.c17.ctg.4	121	23.6	0	.	n	.	0	.1023G	INS	1023	1023	T	72	72	G	41	G	41	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4982	rrsB+	1542	121	95.08	rrsB+.l15.c17.ctg.4	121	23.6	0	HET	.	.	.	C1038T	.	1038	1038	C	87	87	C	19	C,T	0,19	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	334	sat_1	525	525	100.0	sat_1.l6.c4.ctg.1	982	18.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	226	soxR	465	465	100.0	soxR.l15.c4.ctg.1	823	14.4	1	SNP	p	R20H	0	.	.	58	60	CGC	233	235	CGC	19;19;19	C;G;C	18;19;19	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	226	soxR	465	465	100.0	soxR.l15.c4.ctg.1	823	14.4	1	SNP	p	G121D	0	.	.	361	363	GGT	536	538	GGT	30;30;30	G;G;T	30;30;29	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	140	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	579	11.6	1	SNP	p	A12S	0	.	.	34	36	GCA	110	112	GCA	23;23;23	G;C;A	23;23;23	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	814	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l6.c4.ctg.1	1353	31.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	856	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c30.ctg.1	1312	34.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	554	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1170	24.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	882	tetA	1200	1200	100.0	tetA.l15.c4.ctg.1	1676	27.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	532	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1190	23.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	648	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1895	18.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
